Schreiner MediPharm introduces the Digital Display Label, a groundbreaking innovation designed to revolutionize the labeling of investigational drugs in clinical trials. This electronic label with a digital display offers a smart alternative to conventional static labels, enabling real-time updates, process optimization, and accelerated time-to-market.
Addressing Clinical Trial Challenges
Clinical trials demand precision, speed, and flexibility—areas where traditional labeling often falls short. Protocol amendments, regulatory changes, or updates in patient groups and expiry dates typically require manual relabeling, leading to delays, increased costs, and logistical inefficiencies. The Digital Display Label eliminates these bottlenecks with a dynamic and adaptable solution.
Modular and Versatile Design
Built within a durable, reusable plastic housing, the Digital Display Label features a modular adapter system that allows seamless application to a wide range of primary packaging formats, including:
- Flat blister wallets
- Kit boxes
- Round containers such as vials and bottles
Additional features like light protection or visual shielding can be incorporated for transparent containers, enhancing usability across diverse formats.
Real-Time Information, Enhanced Safety
The ability to digitally update label information ensures that patients and clinical staff always access the most current drug data—without relabeling or material waste. This not only improves patient safety but also reduces the risk of trial interruptions due to outdated labeling.
Sustainable and Resource-Efficient
Sustainability is central to Schreiner MediPharm’s innovation. Both the housing and adapter system are reusable, cutting down on waste and material usage. The modular architecture integrates effortlessly with existing packaging systems, eliminating the need for costly redesigns.
A Step Toward the Digital Future
By streamlining clinical trial logistics and enabling real-time, flexible labeling, the Digital Display Label sets a new standard for digital transformation in pharma. It delivers:
- Operational efficiency
- Regulatory adaptability
- Enhanced patient compliance
- Significant cost savings
Schreiner MediPharm’s Digital Display Label is more than a smart label—it’s a strategic leap forward in modernizing clinical trials.